A Study of pemetrexed/cisplatin in chemotherapy-naive Advanced Non Small Cell Lung Cancer (NSCLC).

Trial Profile

A Study of pemetrexed/cisplatin in chemotherapy-naive Advanced Non Small Cell Lung Cancer (NSCLC).

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Apr 2016

At a glance

  • Drugs Pemetrexed (Primary) ; Cisplatin; Gemcitabine
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 May 2012 Actual end date changed from 25 Sep 2008 to 13 Oct 2009 as reported by Chinese Clinical Trial Register.
    • 15 Mar 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top